WO2001022943A8 - A slow release pharmaceutical composition comprising a magnesium oxychloride cement - Google Patents
A slow release pharmaceutical composition comprising a magnesium oxychloride cementInfo
- Publication number
- WO2001022943A8 WO2001022943A8 PCT/ZA2000/000180 ZA0000180W WO0122943A8 WO 2001022943 A8 WO2001022943 A8 WO 2001022943A8 ZA 0000180 W ZA0000180 W ZA 0000180W WO 0122943 A8 WO0122943 A8 WO 0122943A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- release pharmaceutical
- slow release
- pharmaceutical composition
- oxychloride cement
- magnesium oxychloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU78874/00A AU7887400A (en) | 1999-09-29 | 2000-09-29 | A slow release pharmaceutical composition |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA99/6190 | 1999-09-29 | ||
| ZA996190 | 1999-09-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001022943A1 WO2001022943A1 (en) | 2001-04-05 |
| WO2001022943A8 true WO2001022943A8 (en) | 2001-07-19 |
Family
ID=25587935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/ZA2000/000180 Ceased WO2001022943A1 (en) | 1999-09-29 | 2000-09-29 | A slow release pharmaceutical composition comprising a magnesium oxychloride cement |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7887400A (en) |
| WO (1) | WO2001022943A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387412B1 (en) * | 2000-04-14 | 2002-05-14 | Agri-Nutrients Technology Group, Inc. | Storage stable animal mineral granules |
| IL149978A0 (en) * | 2002-06-02 | 2002-12-01 | Biotan Biocides For Paints And | A biocide and method for making the same |
| GB0705792D0 (en) * | 2007-03-26 | 2007-05-02 | Orthogem Ltd | Magnesium oxide cement |
| CN101278928B (en) | 2007-04-06 | 2011-09-07 | 常州高新技术产业开发区三维工业技术研究所有限公司 | Medicament composition containing levocarnitine or its derivatives and use thereof |
| FR2931361B1 (en) | 2008-05-20 | 2012-08-31 | Menvielle Bourg Fabienne Joanny | MAGNESIUM-BASED SYSTEM AND ITS USE IN COSMETICS |
| FR2931359B1 (en) | 2008-05-20 | 2012-12-21 | Menvielle Bourg Fabienne Joanny | USE OF MATRIX FOR EXTENDED RELEASE MAGNESIUM ORAL DELIVERY, AND COMPOSITION CONTAINING SAME |
| AU2010216472B2 (en) * | 2009-02-18 | 2013-07-18 | Sea Qiq As | Mixture of inorganic compounds, preparations containing the mixture and use of the mixture |
| EP2813217A1 (en) | 2013-06-11 | 2014-12-17 | Fabienne Joanny Menvielle-Bourg | Composition for oral administration of magnesium, in association with a composition for the treatment of type 2 diabetes and its complications |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2123693B (en) * | 1982-07-20 | 1987-05-13 | Nat Res Dev | Sustained release device |
| US5273547A (en) * | 1988-04-29 | 1993-12-28 | Carus Corporation | Sorel cementitious composition which time releases permanganate ion |
| GB8820242D0 (en) * | 1988-08-25 | 1988-09-28 | Kent B E | Sustained release device |
-
2000
- 2000-09-29 WO PCT/ZA2000/000180 patent/WO2001022943A1/en not_active Ceased
- 2000-09-29 AU AU78874/00A patent/AU7887400A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001022943A1 (en) | 2001-04-05 |
| AU7887400A (en) | 2001-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1695710T1 (en) | Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it | |
| YU69603A (en) | Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium | |
| WO2006011159A3 (en) | Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability | |
| WO2008128775A3 (en) | Stabilised pharmaceutical composition containing pregabaline | |
| WO2008052033A3 (en) | Ibuprofen composition | |
| MY147641A (en) | Fast release paracetamol tablets | |
| EP1424994A4 (en) | Preparation of sustained release pharmaceutical composition | |
| HUP0102676A3 (en) | Solid, quick dissolving pharmaceutical compositions containing cetrizine | |
| WO2007134158A3 (en) | Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy | |
| WO2006024479A3 (en) | Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin | |
| HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
| CA2378428A1 (en) | Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes | |
| CA2361402A1 (en) | Bis-sulfonamides | |
| HUP0204202A3 (en) | Ibuprofen containing active agent preparation, process for its preparation and pharmaceutical compositions containing it | |
| PL394600A1 (en) | Vinylazocycloalkanyl compound, process for the preparation thereof, its use and pharmaceutical composition | |
| EP2017269A8 (en) | A pharmaceutical composition comprising form II crystalline Ritonavir and a preparation thereof | |
| WO2001022943A8 (en) | A slow release pharmaceutical composition comprising a magnesium oxychloride cement | |
| AU2001275810A1 (en) | The pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis | |
| WO2002050067A3 (en) | Pharmaceutical heterocyclic compounds | |
| CA2429639A1 (en) | Stable azithromycin monohydrate | |
| WO2004108084A3 (en) | Polymorphic forms of naltrexone | |
| ZA200203077B (en) | Ciclesonide contained pharmaceutical composition for application to mucosa. | |
| GB2368014B (en) | Pharmaceutical composition containing citalopram | |
| HUP0301590A3 (en) | Nonpeptide substituted spirobenzoazepines as vasopressin antagonists, pharmaceutical compositions containing them and their preparation | |
| WO2003028624A3 (en) | Levothyroxine compositions and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| CFP | Corrected version of a pamphlet front page |
Free format text: REVISED TITLE RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |